The 2022 ACR/EULAR criteria for MPA, which are currently used for the classification of MPA, assign +6 points to the item of MPO-ANCA positivity and −1 point to the item of PR3-ANCA positivity (7). This evidence concerns the gene MPO and microscopic polyangiitis.